Winston Kung - 20 Apr 2022 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
COO, CFO
Signature
/s/ Robert Ticktin, by power of attorney
Issuer symbol
PMVP
Transactions as of
20 Apr 2022
Net transactions value
+$12,880
Form type
4
Filing time
21 Apr 2022, 16:25:30 UTC
Previous filing
28 Feb 2022
Next filing
22 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMVP Common Stock Options Exercise $12,880 +4,000 +61% $3.22 10,600 20 Apr 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Stock Option (right to buy) Options Exercise $0 -4,000 -1.9% $0.000000 210,034 20 Apr 2022 Common Stock 4,000 $3.22 Direct F1
holding PMVP Stock Option (right to buy) 237,412 20 Apr 2022 Common Stock 237,412 $3.22 See footnote F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is subject to an early exercise provision and is immediately exercisable. The underlying shares vest in accordance with the terms of the option grant.
F2 All of the shares subject to the option are vested and immediately exercisable.
F3 The shares are held of record by the Winston Kung Irrevocable Family Trust for the benefit of the reporting person's immediate family.